| Original language | English (US) |
|---|---|
| Pages (from-to) | 93-97 |
| Number of pages | 5 |
| Journal | Expert Opinion on Investigational Drugs |
| Volume | 28 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2 2019 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Alzheimer’s disease
- glucagon
- glucagon-like peptide
- glucose-dependent insulinotropic peptide
- type 2 diabetes
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS